Bradykinin antagonist quinolines
US5563162A · kind A · utility
38Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 1994 |
| Grant date | Oct 8, 1996 |
| Priority date | — |
| Expiry date | Apr 26, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to new heterocyclic compounds and pharmaceutically acceptable salts thereof. More particularly, this invention relates to new heterocyclic compounds and salts thereof which display bradykinin antagonist activity, to processes for preparing these compounds, to a pharmaceutical composition comprising these compounds, and to methods of using same in the prevention and/or the treatment of bradykinin- or bradykinin analogue-mediated diseases such as allergy, inflammation, autoimmune disease, shock, pain, or the like, in human beings or in animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.